Lynn Kirkpatrick - Net Worth and Insider Trading

Lynn Kirkpatrick Net Worth

The estimated net worth of Lynn Kirkpatrick is at least $513 dollars as of 2024-09-22. Lynn Kirkpatrick is the CEO of Ensysce Biosciences Inc and owns about 1,591 shares of Ensysce Biosciences Inc (ENSC) stock worth over $513. Details can be seen in Lynn Kirkpatrick's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lynn Kirkpatrick has not made any transactions after 2022-05-26 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Lynn Kirkpatrick

To

Lynn Kirkpatrick Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Lynn Kirkpatrick owns 1 companies in total, including Ensysce Biosciences Inc (ENSC) .

Click here to see the complete history of Lynn Kirkpatrick’s form 4 insider trades.

Insider Ownership Summary of Lynn Kirkpatrick

Ticker Comapny Transaction Date Type of Owner
ENSC Ensysce Biosciences Inc 2022-05-26 director & Chief Executive Officer

Lynn Kirkpatrick Latest Holdings Summary

Lynn Kirkpatrick currently owns a total of 1 stock. Lynn Kirkpatrick owns 1,591 shares of Ensysce Biosciences Inc (ENSC) as of May 26, 2022, with a value of $513.

Latest Holdings of Lynn Kirkpatrick

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ENSC Ensysce Biosciences Inc 2022-05-26 1,591 0.32 513

Holding Weightings of Lynn Kirkpatrick


Lynn Kirkpatrick Form 4 Trading Tracker

According to the SEC Form 4 filings, Lynn Kirkpatrick has made a total of 1 transactions in Ensysce Biosciences Inc (ENSC) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Ensysce Biosciences Inc is the acquisition of 404 shares on May 26, 2022, which cost Lynn Kirkpatrick around $48,500.

Insider Trading History of Lynn Kirkpatrick

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Lynn Kirkpatrick Trading Performance

GuruFocus tracks the stock performance after each of Lynn Kirkpatrick's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lynn Kirkpatrick is -20.23%. GuruFocus also compares Lynn Kirkpatrick's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lynn Kirkpatrick within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Lynn Kirkpatrick's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Lynn Kirkpatrick

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.5 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -6.9 LIMIT LIMIT LIMIT LIMIT LIMIT

Lynn Kirkpatrick Ownership Network

Ownership Network List of Lynn Kirkpatrick

No Data

Ownership Network Relation of Lynn Kirkpatrick

Insider Network Chart

Lynn Kirkpatrick Owned Company Details

What does Ensysce Biosciences Inc do?

Who are the key executives at Ensysce Biosciences Inc?

Lynn Kirkpatrick is the director & Chief Executive Officer of Ensysce Biosciences Inc. Other key executives at Ensysce Biosciences Inc include Chief Medical Officer Nilab Osman , Chief Development Officer Linda Pestano , and Chief Business Officer Richard Chester Wright .

Ensysce Biosciences Inc (ENSC) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ensysce Biosciences Inc (ENSC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ensysce Biosciences Inc (ENSC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ensysce Biosciences Inc (ENSC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ensysce Biosciences Inc Insider Transactions

No Available Data

Lynn Kirkpatrick Mailing Address

Above is the net worth, insider trading, and ownership report for Lynn Kirkpatrick. You might contact Lynn Kirkpatrick via mailing address: 110 110th Avenue Ne, Suite 685, Bellevue Wa 98004.